Monday, February 13, 2012

New migraine med shows promise

(HealthDay News) UPDATED 2008-11-24
A new migraine medicine called telcagepant was found safe and effective at treating migraines in a new comparative study with the migraine drug Zomig, and it did so without causing some of the common side effects of current triptan migraine drugs. In a study conducted by drugmaker Merck, researchers found that telcagepant and Zomig were similar in their effectiveness, both of which outperformed a placebo. But telcagepant works differently than triptans such as Zomig, which makes it less likely to cause side effects associated with these drugs. Researchers also say telcagepant may be safer for patients who suffer from both migraines and cardiovascular disease.  Read full story >
See all Migraine News
Related: Zomig

People who read this also read...

  • New Migraine Medicine
  • Migraine Med
  • Can You Have A Migraine From Thyroid Med?
  • Meds Used For Migraine Prophylaxis
  • Getting Rid Of A Headache
  • Holistic Migraine Treatments